Anand Padmanabhan MBBS, PhD

Dr. Anand Padmanabhan, M.B.B.S., Ph.D., has translational research interests in the area of platelet immunology with a focus on heparin-induced thrombocytopenia. He also has clinical and research interests in the use of apheresis therapies in human disease and the collection of cellular blood components for novel cell therapies.

Heparin-induced thrombocytopenia causes more than five deaths each day in the United States. Timely and accurate diagnosis is a challenge. Current testing algorithms frequently lead to overdiagnosis of the condition in some instances and delayed diagnosis in others. Dr. Padmanabhan's research seeks to significantly change the testing paradigm so that early and accurate diagnosis of heparin-induced thrombocytopenia can facilitate timely, appropriate therapy.

His interests in transfusion medicine and cellular therapies include apheresis collections and treatments and platelet transfusion refractoriness. Evidence-based use of apheresis, hematologic cell collections, and optimization of vascular access to facilitate apheresis are particular areas of focus.